Oculis Holding AG (OCS) Free Cash Flow (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Free Cash Flow of -$19.6 million in Q1 2026, up 5.99% quarter-over-quarter from -$20.8 million in Q4 2025, and up 7.12% on a YoY basis from -$18.3 million in Q1 2025.

Oculis Holding AG (OCS) Free Cash Flow (2022 - 2026) Analysis & Trends

Oculis Holding AG's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$19.6 million for Q1 2026.

  • In Q1 2026, Free Cash Flow rose 7.12% year-over-year to -$19.6 million; the TTM figure through Mar 2026 stood at -$77.7 million (down 28.08% YoY), while the FY2025 annual figure was -$82.6 million, down 48.58% from the prior year.
  • Free Cash Flow was -$19.6 million for Q1 2026 at Oculis Holding AG, up from -$20.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$6.8 million in Q4 2022 to a low of -$21.1 million in Q1 2025.
  • Historically, Free Cash Flow has averaged -$15.3 million across 5 years, with a median of -$15.7 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow plunged 136.64% in 2023, then grew 24.53% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$6.8 million in 2022, then slumped by 136.64% to -$16.0 million in 2023, then advanced by 24.53% to -$12.1 million in 2024, then tumbled by 72.3% to -$20.8 million in 2025, then increased by 5.99% to -$19.6 million in 2026.
  • The last three Free Cash Flow figures came in at -$19.6 million (Q1 2026), -$20.8 million (Q4 2025), and -$16.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -1.67 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -2.49 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.29 Bn
9 Abivax 90.15 Bn 90.15 Bn - 63,220.27
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -19.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.58 Mn
Mar 31, 2026 -19.58 Mn
Dec 31, 2025 -20.82 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -16.62 Mn
Sep 30, 2025 -16.62 Mn
Jun 30, 2025 -20.67 Mn
Jun 30, 2025 -20.67 Mn
Mar 31, 2025 -21.08 Mn
Mar 31, 2025 -21.08 Mn
Dec 31, 2024 -12.09 Mn
Dec 31, 2024 -12.09 Mn
Sep 30, 2024 -12.31 Mn
Sep 30, 2024 -12.31 Mn
Jun 30, 2024 -15.19 Mn
Jun 30, 2024 -15.19 Mn
Mar 31, 2024 -15.72 Mn
Mar 31, 2024 -15.72 Mn
Dec 31, 2023 -16.01 Mn
Dec 31, 2023 -16.01 Mn